JMP Securities Downgrades Arena Pharmaceuticals to Market Perform

JMP Securities analyst Jason Butler downgrades Arena Pharmaceuticals (NASDAQ:ARNA) from Market Outperform to Market Perform.

JMP Securities analyst Jason Butler downgrades Arena Pharmaceuticals (NASDAQ:ARNA) from Market Outperform to Market Perform.

Total
0
Shares
Related Posts